This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200203-183OCv1 167/3/418    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fabbri, L. M. Articles by Papi, A. Search for Related Content PubMed PubMed Citation Articles by Fabbri, L. M. Articles by Papi, A.

Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease

Research Center on Asthma and COPD, University of Ferrara, Italy; Departments of Respiratory Diseases and Radiology, University of Modena & Reggio Emilia, Modena, Italy; Department of Respiratory Medicine, University of Skopje, Macedonia; Section of Respiratory Diseases, Department of Clinical and Experimental Medicine, University of Padova, Italy

Correspondence and requests for reprints should be addressed to Leonardo M. Fabbri, Department of Respiratory Diseases, University of Modena & Reggio Emilia, Policlinico, Via del Pozzo, 71, 41100 Modena, Italy. E-mail: fabbri.leonardo{at}unimo.it

To determine whether patients with fixed airflow obstruction have distinct pathologic and functional characteristics depending on a history of either asthma or chronic obstructive pulmonary disease (COPD), we characterized 46 consecutive outpatients presenting with fixed airflow obstruction by clinical history, pulmonary function tests, exhaled nitric oxide, sputum analysis, bronchoalveolar lavage, bronchial biopsy, and high-resolution computed tomography chest scans. Subjects with a history of COPD (n = 27) and subjects with a history of asthma (n = 19) had a similar degree of fixed airflow obstruction (FEV₁: 56 ± 2 versus 56 ± 3% predicted) and airway hyperresponsiveness (PC₂₀FEV₁: 2.81 [3.1] versus 1.17 [3.3]). Subjects with a history of asthma had significantly more eosinophils in peripheral blood, sputum, bronchoalveolar lavage, and airway mucosa; fewer neutrophils in sputum and bronchoalveolar lavage fluid; a higher CD4+/CD8+ ratio of T cells infiltrating the airway mucosa; and a thicker reticular layer of the epithelial basement membrane. They also had significantly lower residual volume, higher diffusing capacity, higher exhaled nitric oxide, lower high-resolution computed tomography scan emphysema score, and greater reversibility to bronchodilator and steroids. In conclusion, despite similar fixed airflow obstruction, subjects with a history of asthma have distinct characteristics compared with subjects with a history of COPD and should be properly identified and treated.

Key Words: smoking • eosinophil • nitric oxide • bronchitis • emphysema

This article has been cited by other articles:

				K. G. Lim and C. Mottram The Use of Fraction of Exhaled Nitric Oxide in Pulmonary Practice Chest, May 1, 2008; 133(5): 1232 - 1242. [Abstract] [Full Text] [PDF]

				M. Yamasaki, H.-R. Kang, R. J. Homer, S. P. Chapoval, S. J. Cho, B. J. Lee, J. A. Elias, and C. G. Lee P21 Regulates TGF-{beta}1-Induced Pulmonary Responses via a TNF-{alpha}-Signaling Pathway Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 346 - 353. [Abstract] [Full Text] [PDF]

				G. Viegi, F. Pistelli, D. L. Sherrill, S. Maio, S. Baldacci, and L. Carrozzi Definition, epidemiology and natural history of COPD Eur. Respir. J., November 1, 2007; 30(5): 993 - 1013. [Abstract] [Full Text] [PDF]

				J. Bourbeau, P. Christodoulopoulos, F. Maltais, Y. Yamauchi, R. Olivenstein, and Q. Hamid Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial Thorax, November 1, 2007; 62(11): 938 - 943. [Abstract] [Full Text] [PDF]

				J. Chang and Z. Mosenifar Differentiating COPD From Asthma in Clinical Practice J Intensive Care Med, September 1, 2007; 22(5): 300 - 309. [Abstract] [PDF]

				A. M. Slats, K. Janssen, A. van Schadewijk, D. T. van der Plas, R. Schot, J. G. van den Aardweg, J. C. de Jongste, P. S. Hiemstra, T. Mauad, K. F. Rabe, et al. Bronchial Inflammation and Airway Responses to Deep Inspiration in Asthma and Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 15, 2007; 176(2): 121 - 128. [Abstract] [Full Text] [PDF]

				G. Turato, S. Baraldo, R. Zuin, and M. Saetta The laws of attraction: chemokines, neutrophils and eosinophils in severe exacerbations of asthma Thorax, June 1, 2007; 62(6): 465 - 466. [Full Text] [PDF]

				J.L. Wright and A. Churg Current Concepts in Mechanisms of Emphysema Toxicol Pathol, January 1, 2007; 35(1): 111 - 115. [Abstract] [PDF]

				G M Turino Emphysema in COPD: consequences and causes. Thorax, December 1, 2006; 61(12): 1031 - 1036. [Full Text] [PDF]

				D R Taylor, M W Pijnenburg, A D Smith, and J C D Jongste Exhaled nitric oxide measurements: clinical application and interpretation. Thorax, September 1, 2006; 61(9): 817 - 827. [Abstract] [Full Text] [PDF]

				P. J. Barnes Against the dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases. Am. J. Respir. Crit. Care Med., August 1, 2006; 174(3): 240 - 243. [Full Text] [PDF]

				P. J. Barnes, B. Chowdhury, S. A. Kharitonov, H. Magnussen, C. P. Page, D. Postma, and M. Saetta Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 6 - 14. [Abstract] [Full Text] [PDF]

				A. Papi, C. M. Bellettato, F. Braccioni, M. Romagnoli, P. Casolari, G. Caramori, L. M. Fabbri, and S. L. Johnston Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1114 - 1121. [Abstract] [Full Text] [PDF]

				I. D. Pavord, S. S. Birring, M. Berry, R. H. Green, C. E. Brightling, and A. J. Wardlaw Multiple inflammatory hits and the pathogenesis of severe airway disease. Eur. Respir. J., May 1, 2006; 27(5): 884 - 888. [Abstract] [Full Text] [PDF]

				R O'Donnell, D Breen, S Wilson, and R Djukanovic Inflammatory cells in the airways in COPD Thorax, May 1, 2006; 61(5): 448 - 454. [Abstract] [Full Text] [PDF]

				P. W. Jones and A. G. N. Agusti Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur. Respir. J., April 1, 2006; 27(4): 822 - 832. [Abstract] [Full Text] [PDF]

				J. Choi, L. A. Hoffman, G. W. Rodway, and J. M. Sethi Markers of lung disease in exhaled breath: nitric oxide. Biol Res Nurs, April 1, 2006; 7(4): 241 - 255. [Abstract] [PDF]

				N. C. Barnes, Y.-S. Qiu, I. D. Pavord, D. Parker, P. A. Davis, J. Zhu, M. Johnson, N. C. Thomson, P. K. Jeffery, and on behalf of the SCO30005 Study Group Antiinflammatory Effects of Salmeterol/Fluticasone Propionate in Chronic Obstructive Lung Disease Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 736 - 743. [Abstract] [Full Text] [PDF]

				J Vestbo and J C Hogg Convergence of the epidemiology and pathology of COPD Thorax, January 1, 2006; 61(1): 86 - 88. [Abstract] [Full Text] [PDF]

				J. Moorman, M. Saad, S. Kosseifi, and G. Krishnaswamy Hepatitis C Virus and the Lung: Implications for Therapy Chest, October 1, 2005; 128(4): 2882 - 2892. [Abstract] [Full Text] [PDF]

				A. Bruno, P. Chanez, G. Chiappara, L. Siena, S. Giammanco, M. Gjomarkaj, G. Bonsignore, J. Bousquet, and A. M. Vignola Does leptin play a cytokine-like role within the airways of COPD patients? Eur. Respir. J., September 1, 2005; 26(3): 398 - 405. [Abstract] [Full Text] [PDF]

				P. J. Barnes New approaches to COPD Eur. Respir. Rev., September 1, 2005; 14(94): 2 - 11. [Abstract] [Full Text] [PDF]

				A. D. Smith, J. O. Cowan, K. P. Brassett, S. Filsell, C. McLachlan, G. Monti-Sheehan, G. P. Herbison, and D. R. Taylor Exhaled Nitric Oxide: A Predictor of Steroid Response Am. J. Respir. Crit. Care Med., August 15, 2005; 172(4): 453 - 459. [Abstract] [Full Text] [PDF]

				C. Brindicci, K. Ito, O. Resta, N. B. Pride, P. J. Barnes, and S. A. Kharitonov Exhaled nitric oxide from lung periphery is increased in COPD Eur. Respir. J., July 1, 2005; 26(1): 52 - 59. [Abstract] [Full Text] [PDF]

				P. J. Barnes and R. A. Stockley COPD: current therapeutic interventions and future approaches Eur. Respir. J., June 1, 2005; 25(6): 1084 - 1106. [Abstract] [Full Text] [PDF]

				K. Kostikas, M. Gaga, G. Papatheodorou, T. Karamanis, D. Orphanidou, and S. Loukides Leukotriene B4 in Exhaled Breath Condensate and Sputum Supernatant in Patients With COPD and Asthma Chest, May 1, 2005; 127(5): 1553 - 1559. [Abstract] [Full Text] [PDF]

				M. Corradi, P. Pignatti, P. Manini, R. Andreoli, M. Goldoni, M. Poppa, G. Moscato, B. Balbi, and A. Mutti Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation Eur. Respir. J., December 1, 2004; 24(6): 1011 - 1017. [Abstract] [Full Text] [PDF]

				P. J. Barnes Mediators of Chronic Obstructive Pulmonary Disease Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548. [Abstract] [Full Text] [PDF]

				J. F. Donohue and J. A. Ohar Effects of Corticosteroids on Lung Function in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 152 - 160. [Abstract] [Full Text] [PDF]

				P. K. Jeffery Remodeling and Inflammation of Bronchi in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 176 - 183. [Abstract] [Full Text] [PDF]

				P. Chanez, A. Bourdin, I. Vachier, P. Godard, J. Bousquet, and A. M. Vignola Effects of Inhaled Corticosteroids on Pathology in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 184 - 190. [Abstract] [Full Text] [PDF]

				S. A. Kharitonov and P. J. Barnes Effects of Corticosteroids on Noninvasive Biomarkers of Inflammation in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 191 - 199. [Abstract] [Full Text] [PDF]

				M. G. Belvisi Regulation of Inflammatory Cell Function by Corticosteroids Proceedings of the ATS, November 1, 2004; 1(3): 207 - 214. [Abstract] [Full Text] [PDF]

				G. Viegi, G. Matteelli, A. Angino, A. Scognamiglio, S. Baldacci, J. B. Soriano, and L. Carrozzi The Proportional Venn Diagram of Obstructive Lung Disease in the Italian General Population Chest, October 1, 2004; 126(4): 1093 - 1101. [Abstract] [Full Text] [PDF]

				A. ten Brinke, A. H. Zwinderman, P. J. Sterk, K. F. Rabe, and E. H. Bel "Refractory" Eosinophilic Airway Inflammation in Severe Asthma: Effect of Parenteral Corticosteroids Am. J. Respir. Crit. Care Med., September 15, 2004; 170(6): 601 - 605. [Abstract] [Full Text] [PDF]

				F. C. Sciurba Physiologic Similarities and Differences Between COPD and Asthma Chest, August 1, 2004; 126(2_suppl_1): 117S - 124S. [Abstract] [Full Text] [PDF]

				J. F. Donohue Therapeutic Responses in Asthma and COPD: Bronchodilators Chest, August 1, 2004; 126(2_suppl_1): 125S - 137S. [Abstract] [Full Text] [PDF]

				M. Gaga Fixed obstruction in severe asthma: not just a matter of time Eur. Respir. J., July 1, 2004; 24(1): 8 - 10. [Full Text] [PDF]

				M. Cazzola and R. Dahl Inhaled Combination Therapy With Long-Acting {beta}2-Agonists and Corticosteroids in Stable COPD Chest, July 1, 2004; 126(1): 220 - 237. [Abstract] [Full Text] [PDF]

				D. C. Grootendorst and K. F. Rabe Mechanisms of Bronchial Hyperreactivity in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2004; 1(2): 77 - 87. [Abstract] [Full Text] [PDF]

				H. Kanazawa, K. Hirata, and J. Yoshikawa Increased Responses to Inhaled Oxitropium Bromide in Asthmatic Patients With Active Hepatitis C Virus Infection Chest, April 1, 2004; 125(4): 1368 - 1371. [Abstract] [Full Text] [PDF]

				R de Marco, S Accordini, I Cerveri, A Corsico, J Sunyer, F Neukirch, N Kunzli, B Leynaert, C Janson, T Gislason, et al. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages Thorax, February 1, 2004; 59(2): 120 - 125. [Abstract] [Full Text] [PDF]

				M. J. Tobin Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2003 Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 265 - 276. [Full Text] [PDF]

				M. J. Tobin Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2003 Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 301 - 313. [Full Text] [PDF]

				E. H. Bel Smoking: A Neglected Cause of Glucocorticoid Resistance in Asthma Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1265 - 1266. [Full Text] [PDF]

				P.J. Barnes, S.D. Shapiro, and R.A. Pauwels Chronic obstructive pulmonary disease: molecular and cellularmechanisms Eur. Respir. J., October 1, 2003; 22(4): 672 - 688. [Abstract] [Full Text] [PDF]

				The pharmacoepidemiology of COPD: Recent advances and methodological discussion Eur. Respir. J., September 1, 2003; 22(43_suppl): 1S - 44s. [Full Text] [PDF]

				S. C. H. Chan, D. K. Y. Shum, and M. S. M. Ip Sputum Sol Neutrophil Elastase Activity in Bronchiectasis: Differential Modulation by Syndecan-1 Am. J. Respir. Crit. Care Med., July 15, 2003; 168(2): 192 - 198. [Abstract] [Full Text] [PDF]